HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing Zhou Selected Research

polycystic kidney disease 2 protein

12/2017Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
10/2010Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease.
4/2003Native polycystin 2 functions as a plasma membrane Ca2+-permeable cation channel in renal epithelia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jing Zhou Research Topics

Disease

270Neoplasms (Cancer)
11/2022 - 08/2002
69Inflammation (Inflammations)
11/2022 - 10/2007
64Infections
11/2022 - 03/2003
44Neoplasm Metastasis (Metastasis)
07/2022 - 08/2002
39Breast Neoplasms (Breast Cancer)
01/2022 - 11/2011
32Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2002
23Autosomal Dominant Polycystic Kidney (ADPKD)
01/2019 - 03/2002
22Cysts
11/2020 - 01/2003
21Lung Neoplasms (Lung Cancer)
08/2022 - 01/2009
21Carcinogenesis
01/2022 - 02/2003
21Carcinoma (Carcinomatosis)
08/2021 - 05/2004
19Hypoxia (Hypoxemia)
07/2022 - 02/2008
18Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 05/2008
18COVID-19
01/2022 - 01/2020
17Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2022 - 01/2011
17Pain (Aches)
01/2022 - 10/2007
17Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2012
15Hemorrhage
09/2022 - 05/2009
15Fibrosis (Cirrhosis)
04/2022 - 06/2011
15Wounds and Injuries (Trauma)
01/2022 - 04/2008
15Polycystic Kidney Diseases (Polycystic Kidney Disease)
11/2020 - 02/2002
14Pancreatitis
06/2022 - 08/2015
13Spinal Cord Injuries (Spinal Cord Injury)
11/2022 - 02/2014
13Insulin Resistance
10/2022 - 03/2010
13Sepsis (Septicemia)
01/2022 - 01/2014
13Necrosis
05/2021 - 10/2015
12Atherosclerosis
05/2022 - 12/2008
12Type 2 Diabetes Mellitus (MODY)
01/2022 - 06/2009
12Arthritis (Polyarthritis)
01/2022 - 04/2004
12Obesity
08/2021 - 11/2007
11Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2022 - 01/2015
11Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 07/2012
11Liver Neoplasms (Liver Cancer)
06/2021 - 05/2009
10Alzheimer Disease (Alzheimer's Disease)
10/2022 - 08/2011
10Myocardial Infarction
06/2022 - 01/2013
10Experimental Arthritis
01/2022 - 08/2005
10Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 05/2007
10Weight Loss (Weight Reduction)
04/2021 - 07/2011
10Traumatic Brain Injuries (Traumatic Brain Injury)
10/2020 - 03/2009
9Pneumonia (Pneumonitis)
08/2022 - 01/2008
9Colonic Neoplasms (Colon Cancer)
07/2022 - 01/2018
9Prostatic Neoplasms (Prostate Cancer)
07/2022 - 05/2004
9Autoimmune Diseases (Autoimmune Disease)
01/2022 - 07/2009
9Leukemia
01/2022 - 05/2009
9Ovarian Neoplasms (Ovarian Cancer)
12/2020 - 09/2008
9Ischemia
10/2020 - 01/2010
8Critical Illness (Critically Ill)
08/2022 - 01/2018
8Body Weight (Weight, Body)
07/2022 - 03/2014
8Hyperplasia
05/2022 - 12/2008
8Acute Necrotizing Pancreatitis
01/2022 - 01/2015
8Asthma (Bronchial Asthma)
12/2021 - 12/2012
8Hypertension (High Blood Pressure)
04/2021 - 06/2009

Drug/Important Bio-Agent (IBA)

123Proteins (Proteins, Gene)FDA Link
11/2022 - 02/2003
57Pharmaceutical PreparationsIBA
08/2022 - 03/2004
48Biomarkers (Surrogate Marker)IBA
06/2022 - 09/2009
44MicroRNAs (MicroRNA)IBA
01/2022 - 10/2009
43CytokinesIBA
01/2022 - 03/2009
34Messenger RNA (mRNA)IBA
09/2022 - 05/2007
28Biological ProductsIBA
01/2022 - 05/2010
21LipidsIBA
09/2022 - 06/2008
20RNA (Ribonucleic Acid)IBA
04/2022 - 08/2002
20LigandsIBA
01/2022 - 07/2006
19Long Noncoding RNAIBA
12/2021 - 01/2013
18DNA (Deoxyribonucleic Acid)IBA
04/2022 - 09/2003
17Glucose (Dextrose)FDA LinkGeneric
07/2022 - 04/2005
17Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2012
17EnzymesIBA
10/2021 - 04/2013
16salicylhydroxamic acid (SHAM)IBA
09/2022 - 01/2013
16Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 07/2008
16Peptides (Polypeptides)IBA
01/2022 - 05/2004
15Interleukin-6 (Interleukin 6)IBA
11/2022 - 01/2008
15Therapeutic UsesIBA
01/2022 - 06/2007
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2022 - 01/2010
14AntioxidantsIBA
02/2022 - 10/2005
14Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2008
14Small Interfering RNA (siRNA)IBA
11/2021 - 07/2006
13VaccinesIBA
11/2022 - 07/2011
13AntigensIBA
01/2022 - 11/2004
11Antiviral Agents (Antivirals)IBA
09/2022 - 01/2008
11Indicators and Reagents (Reagents)IBA
01/2022 - 01/2011
11CollagenIBA
01/2022 - 01/2004
10Circular RNAIBA
05/2022 - 01/2018
9CateninsIBA
02/2022 - 06/2011
9Phosphotransferases (Kinase)IBA
01/2022 - 07/2006
9IronIBA
11/2021 - 07/2012
9Interleukin-10 (Interleukin 10)IBA
08/2021 - 08/2014
8ORALIT (ORS)IBA
08/2022 - 06/2009
8Amino AcidsFDA Link
03/2022 - 02/2008
8Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 12/2006
8AntibodiesIBA
01/2022 - 03/2004
8LuciferasesIBA
01/2022 - 05/2014
8InterleukinsIBA
12/2021 - 03/2009
8Triglycerides (Triacylglycerol)IBA
01/2021 - 06/2009

Therapy/Procedure

143Therapeutics
11/2022 - 05/2002
35Drug Therapy (Chemotherapy)
06/2022 - 04/2005
21Immunotherapy
08/2022 - 09/2015
18Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 01/2013
17Electroacupuncture
07/2022 - 02/2015
10Ligation
11/2021 - 01/2008
10Precision Medicine
09/2019 - 01/2016